Biomarkers in Molecularly Targeted Therapy for Cancer

E-ISSN： 2210-3104|1|2|110-118

ISSN： 2210-3090

Source： Recent Patents on Biomarkers, Vol.1, Iss.2, 2011-05, pp. : 110-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalization of Targeted Therapy in Advanced Thyroid Cancer

Current Genomics, Vol. 15, Iss. 3, 2014-01 ,pp. : 190-202

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date

Recent Patents on Biomarkers, Vol. 4, Iss. 2, 2014-05 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for targeted gene therapy

By Harris J.D. Lemoine N.R.

Trends in Genetics, Vol. 12, Iss. 10, 1996-10 ,pp. : 400-405

Elsevier

Access to resources Recommend Favorite

Editorial [Hot Topic: Transcriptomic Biomarkers in Cancer Diagnosis, Prognosis and Therapy Monitoring (Guest Editor: Monica Neagu)]

Recent Patents on Biomarkers, Vol. 2, Iss. 2, 2012-05 ,pp. : 73-74

Bentham Science Publishers

Access to resources Recommend Favorite

New Targeted Therapies for Thyroid Cancer

Current Genomics, Vol. 12, Iss. 8, 2011-12 ,pp. : 626-631

Bentham Science Publishers

Access to resources Recommend Favorite